Literature DB >> 35260010

Development of monoclonal antibodies specific to Marek disease virus-EcoRI-Q (Meq) for the immunohistochemical diagnosis of Marek disease using formalin-fixed, paraffin-embedded samples.

Aoi Kurokawa1, Yu Yamamoto1.   

Abstract

Marek disease (MD) is a viral disease characterized by the development of lymphoma in poultry. Although morphologic confirmation of lymphoma is used to diagnose MD, immunohistochemical detection of MD virus-EcoRI-Q (Meq), which is a viral protein that is expressed exclusively in MD tumor cells, would further improve the accuracy of diagnosis. We developed monoclonal antibodies (mAbs) that specifically detect Meq by immunohistochemistry (IHC) using formalin-fixed, paraffin-embedded (FFPE) sections. We evaluated the sensitivity and specificity of 14 mAbs that we produced, using FFPE samples of MDCC-MSB1 cells, MD tumor tissues, and tissues of uninfected chickens. Four different antigen retrieval conditions were investigated. Thirteen mAbs reacted with Meq in FFPE sections, but immunohistochemical reactivity and specificity varied depending on the mAb and antigen retrieval condition; heat-induced antigen retrieval (HIAR) was more effective at detecting Meq than the other tested conditions. HIAR pH 9 tended to increase immunoreactivity and decrease specificity. Of the 5 mAbs that immunoreacted strongly with Meq without nonspecific reactions under the optimal antigen retrieval conditions, 3 mAbs (1C1-121, 3A3-112, 5F7-82) did not produce background staining of tumor or non-tumor tissues; 2 mAbs (2C5-11, 4A5-54) produced background staining. The mAb 6B5-128 reacted moderately with Meq without nonspecific reactions and background staining. The remaining mAbs showed weak immunoreactivity or problematic nonspecific reactions. Our results suggest that some of our developed mAbs can be used in IHC to detect Meq in FFPE sections with high specificity, and that the use of IHC may greatly improve the diagnosis of MD.

Entities:  

Keywords:  Marek disease; immunohistochemistry; meq; monoclonal antibody

Mesh:

Substances:

Year:  2022        PMID: 35260010      PMCID: PMC9254047          DOI: 10.1177/10406387221080444

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.569


  27 in total

Review 1.  Genetic resistance to Marek's disease.

Authors:  L D Bacon; H D Hunt; H H Cheng
Journal:  Curr Top Microbiol Immunol       Date:  2001       Impact factor: 4.291

Review 2.  Protective efficacy of Marek's disease vaccines.

Authors:  R L Witter
Journal:  Curr Top Microbiol Immunol       Date:  2001       Impact factor: 4.291

3.  Interaction of Marek's disease virus oncoprotein Meq with heat-shock protein 70 in lymphoid tumour cells.

Authors:  Yuguang Zhao; Dominic Kurian; Hongtao Xu; Lawrence Petherbridge; Lorraine P Smith; Lawrence Hunt; Venugopal Nair
Journal:  J Gen Virol       Date:  2009-06-03       Impact factor: 3.891

4.  Characterization of very virulent Marek's disease viruses isolated in Japan.

Authors:  K Imai; N Yuasa; H Iwakiri; K Nakamura; H Hihara; T Ishita; A Inamoto; I Okamoto; K Ohta; M Maeda
Journal:  Avian Pathol       Date:  1992       Impact factor: 3.378

5.  Development of reliable techniques for the differential diagnosis of avian tumour viruses by immunohistochemistry and polymerase chain reaction from formalin-fixed paraffin-embedded tissue sections.

Authors:  Husnain Ahmed; Jody Mays; Matti Kiupel; John R Dunn
Journal:  Avian Pathol       Date:  2018-04-11       Impact factor: 3.378

6.  Expression of Marek's Disease Virus Oncoprotein Meq During Infection in the Natural Host.

Authors:  S-H Sheldon Tai; Cari Hearn; Sudawapee Umthong; Olga Agafitei; Hans H Cheng; John R Dunn; Masahiro Niikura
Journal:  Virology       Date:  2017-02-01       Impact factor: 3.616

7.  Transformation of T-lymphocyte subsets by Marek's disease herpesvirus.

Authors:  K A Schat; C L Chen; B W Calnek; D Char
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

8.  Comparative analysis of Marek's disease virus (MDV) glycoprotein-, lytic antigen pp38- and transformation antigen Meq-encoding genes: association of meq mutations with MDVs of high virulence.

Authors:  Christine E Shamblin; Natalie Greene; Vaithilingaraja Arumugaswami; Robert L Dienglewicz; Mark S Parcells
Journal:  Vet Microbiol       Date:  2004-09-08       Impact factor: 3.293

9.  Characterizing the histopathology of natural co-infection with Marek's disease virus and subgroup J avian leucosis virus in egg-laying hens.

Authors:  Yawen Wen; Qi Huang; Chengcheng Yang; Ling Pan; Guijun Wang; Kezong Qi; Hongmei Liu
Journal:  Avian Pathol       Date:  2017-09-25       Impact factor: 3.378

10.  Spotlight on avian pathology: Marek's disease.

Authors:  Venugopal Nair
Journal:  Avian Pathol       Date:  2018-07-03       Impact factor: 3.378

View more
  1 in total

1.  A New Strategy for Efficient Screening and Identification of Monoclonal Antibodies against Oncogenic Avian Herpesvirus Utilizing CRISPR/Cas9-Based Gene-Editing Technology.

Authors:  Man Teng; Zi-Yu Zhou; Yongxiu Yao; Venugopal Nair; Gai-Ping Zhang; Jun Luo
Journal:  Viruses       Date:  2022-09-14       Impact factor: 5.818

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.